The Association for Accessible Medicines is a Washington, D.C.-based trade group that represents makers of generic and biosimilar drugs. It lobbies Congress on issues affecting pharmacies, Medicare and Medicaid, and the drug supply chain—pushing for laws to speed generic and biosimilar competition and reduce regulatory barriers. Recent filings show work on bills like the Drug Competition Enhancement Act and measures to ease biosimilar rules.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ALEXANDER PERKINS
The latest disclosures for this client.
MEHLMAN CONSULTING, INC.
Q1MEHLMAN CONSULTING, INC.
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
MEHLMAN CONSULTING, INC.
ALYENE MLINAR
MEHLMAN CONSULTING, INC.
ANNIE WOLF
MEHLMAN CONSULTING, INC.
BRUCE MEHLMAN
MEHLMAN CONSULTING, INC.
CAITLIN VAN SANT
MEHLMAN CONSULTING, INC.
DEAN ROSEN
MEHLMAN CONSULTING, INC.
ELISE FINLEY PICKERING
MEHLMAN CONSULTING, INC.
HELEN TOLAR
MEHLMAN CONSULTING, INC.
MEHLMAN CONSULTING, INC.
Q3MEHLMAN CONSULTING, INC.
Q2MEHLMAN CONSULTING, INC.
Q1